Clinical Trial Update: Developing World Study for RotaTeq™ (V260-015)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 developing-world trial of the rotavirus vaccine RotaTeq completed, with results posted in 2010, assessing prevention of rotavirus gastroenteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Vomiting, Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2010-05-13